Sou Hu Cai Jing·2025-12-18 08:13Core Viewpoint - The collaboration between Shengxiang Biology and Ali Health aims to promote the popularization of home rapid testing services, enhancing the integration of medical, testing, and pharmaceutical services [1]. Group 1: Strategic Collaboration - Shengxiang Biology has announced a strategic partnership with Ali Health to advance home rapid testing services [1]. - The collaboration is part of the company's "three-in-one" model and "medical-testing-pharmaceutical integration" ecosystem [1]. Group 2: Project Details - An example project, the "12-in-1 respiratory virus and bacteria test," allows users to complete professional-level testing from home, with results available in an average of 3 hours [1]. - This initiative aims to provide scientific medication guidance and alleviate the pressure on healthcare systems during flu seasons [1]. Group 3: Future Plans - The partnership will focus on standardizing home rapid testing services and exploring additional home-based applications for infectious disease testing [1]. - The goal is to create a new health service ecosystem that integrates "Internet + healthcare + instant delivery," promoting precision and accessibility in serious medical care [1]. Group 4: Health Management - The collaboration seeks to drive health demand towards proactive and consumer-oriented approaches, leading to a more serious, scientific, and personalized direction in health consumption [1]. - Customized health management solutions are intended to benefit every individual [1].